Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Namwiwat Medical PCLBKK:NAM 39 Receivables Turnover is 0.67 as of Mar. 2026. GuruFocus rates BKK:NAM with a GF Score™ of 39/100 and a GF Value™ of ฿5.97 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Namwiwat Medical PCL ranks worse than 85.82% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Namwiwat Medical PCL's Revenue for the
three
months ended in Mar. 2026 was ฿377 Mil. Namwiwat Medical PCL's average Accounts Receivable for the
three
months ended in Mar. 2026 was ฿565 Mil.
Hence, Namwiwat Medical PCL's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.67.
Namwiwat Medical PCL (BKK:NAM) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Namwiwat Medical PCL Receivables Turnover Related Terms
Namwiwat Medical PCL Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Namwiwat Medical PCL's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:NAM vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Namwiwat Medical PCL's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Namwiwat Medical PCL Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Namwiwat Medical PCL's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Namwiwat Medical PCL's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Namwiwat Medical PCL (BKK:NAM) has a Receivables Turnover of 0.67 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Namwiwat Medical PCL and its competitors. According to the industry distribution chart, Namwiwat Medical PCL ranks #696 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 85.8%.
Is Namwiwat Medical PCL's Receivables Turnover too high?
Namwiwat Medical PCL's current Receivables Turnover is 0.67. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Namwiwat Medical PCL's value of 0.67 is 87.8% below this industry median. Based on the distribution chart, Namwiwat Medical PCL ranks #696 out of 811 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Namwiwat Medical PCL has a GF Score™ of 39/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Namwiwat Medical PCL ranks #696 out of 811 companies for Receivables Turnover. This places Namwiwat Medical PCL in the lower half of its industry. The industry median Receivables Turnover is 5.51. Namwiwat Medical PCL's value of 0.67 is 87.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Namwiwat Medical PCL's current Receivables Turnover of 0.67 is 87.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Namwiwat Medical PCL and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Namwiwat Medical PCL's current Receivables Turnover is 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿5.97, compared to a current price of ฿3.38 — trading 43.4% below its estimated fair value. The current Receivables Turnover is 0.67 and 87.8% below the Medical Devices & Instruments industry median of 5.51. Namwiwat Medical PCL's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Receivables Turnover is 0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?
Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued.
The current stock price of ฿3.38 is trading 43.4% below its estimated GF Value™ of ฿5.97.
GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.
Key valuation signals for BKK:NAM:
Receivables Turnover: 0.67
GF Value™: ฿5.97 vs. price of ฿3.38 (43.4% below fair value)
Industry Position: 87.8% below the Medical Devices & Instruments median (#696 of 811)
No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
39GF Score
Get the complete analysis for BKK:NAM
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NAM has been successfully added to your 
